7-O-acylpaclitaxel analogues: Potential probes to map the paclitaxel binding site

Bioorganic and Medicinal Chemistry Letters

Volumn 7, Issue 14, 1997, Pages 1829-1832

  Georg, Gunda I ^a   Liu, Yanbin ^a   Boge, Thomas C ^a,b   Himes, Richard H ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

7 O BENZOYLPACLITAXEL; 7 O CHLOROACETYLPACLITAXEL; PACLITAXEL; TAXANE DERIVATIVE; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING SITE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; DRUG BINDING; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY; MASS SPECTROMETRY; MELANOMA B16; MICROTUBULE; MICROTUBULE ASSEMBLY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; STRUCTURE ACTIVITY RELATION;

EID: 0030838561     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(97)00329-6     Document Type: Article

References (34)

1. For recent monographs, see: Taxol® Science and Applications; Suffness, M., Ed.; CRC: Boca Raton, 1995. The Chemistry and Pharmacology of Taxol® and Its Derivatives; Farina, V., Ed.; Elsevier: Amsterdam, 1995. Taxane Anticancer Agents: Basic Science and Current Status; Georg, G. I.; Chen, T. T.; Ojima, I.; Vyas, D. M., Eds.; American Chemical Society: Washington, DC, 1995; ACS Symposium Series 583.
2. For recent monographs, see: Taxol® Science and Applications; Suffness, M., Ed.; CRC: Boca Raton, 1995. The Chemistry and Pharmacology of Taxol® and Its Derivatives; Farina, V., Ed.; Elsevier: Amsterdam, 1995. Taxane Anticancer Agents: Basic Science and Current Status; Georg, G. I.; Chen, T. T.; Ojima, I.; Vyas, D. M., Eds.; American Chemical Society: Washington, DC, 1995; ACS Symposium Series 583.
3. For recent monographs, see: Taxol® Science and Applications; Suffness, M., Ed.; CRC: Boca Raton, 1995. The Chemistry and Pharmacology of Taxol® and Its Derivatives; Farina, V., Ed.; Elsevier: Amsterdam, 1995. Taxane Anticancer Agents: Basic Science and Current Status; Georg, G. I.; Chen, T. T.; Ojima, I.; Vyas, D. M., Eds.; American Chemical Society: Washington, DC, 1995; ACS Symposium Series 583.
4. Holmes, F. A.; Kudelka, A. P.; Kavanagh, J. J.; Huber, M. H.; Ajani, J. A.; Valero, V. In Taxane Anticancer Agents: Basic Science and Current Status; Georg, G. I.; Chen, T. T.; Ojima, I.; Vyas, D. M., Eds.; American Chemical Society: Washington, DC, 1995; ACS Symposium Series 583; pp 31-57.
5. Schiff, P. B.; Fant, J.; Horwitz, S. B. Nature, (London) 1979, 277, 665.
6. Derry, W. B.; Wilson, L.; Jordan, M. A. Biochemistry 1995, 34, 2203.
7. Jordan, M. A.; Wendell, K.; Gardiner, S.; Derry, W. B.; Copp, H.; Wilson, L. Cancer Res. 1996, 56, 816.
8. Georg, G. I.; Harriman, G. C. B.; Himes, R. H.; Mejillano, M. R. Bioorg. Med. Chem. Lett. 1992, 2, 735.
9. Georg, G. I.; Harriman, G. C. B.; Park, H.; Himes, R. H. Bioorg. Med. Chem. Lett. 1994, 4, 487.
10. Georg, G. I.; Boge, T. C.; Cheruvallath, Z. S.; Harriman, G. C. B.; Hepperle, M.; Park, H.; Himes, R. H. Bioorg. Med. Chem. Lett. 1994, 4, 335.
11. Carboni, J. M.; Farina, V.; Rao, S.; Hauck, S. I.; Horwitz, S. B.; Ringel, I. J. Med. Chem. 1993, 36, 513.
12. Chaudhary, A. G.; Gharpure, M. M.; Rimoldi, J. M.; Chordia, M. D.; Gunatilaka, A. A. L.; Kingston, D. G. I.; Grover, S.; Lin, C. M.; Hamel, E. J. Am. Chem. Soc. 1994, 116, 4097.
13. Combeau, C.; Commerçon, A.; Mioskowski, C.; Rousseau, B.; Aubert, F.; Goeldner, M. Biochemistry 1994, 33, 6676.
14. Dasgupta, D.; Park, H.; Harriman, G. C. B.; Georg, G. I.; Himes, R. H. J. Med. Chem. 1994, 37, 2976.
15. Rimoldi, J. M.; Kingston, D. G. I.; Chaudhary, A. G.; Samaranayake, G.; Grover, S.; Hamel, E. J. Nat. Prod. 1993, 56, 1313.
16. Swindell, C. S.; Heerding, J. M.; Krauss, N. E.; Horwitz, S. B.; Rao, S.; Ringel, I. J. Med. Chem. 1994, 37, 1446.
17. Rao, S.; Horwitz, S. B.; Ringel, I. J. Natl. Cancer Inst. 1992, 84, 785.
18. Rao, S.; Krauss, N. E.; Heerding, J. M.; Swindell, C. S.; Ringel, I.; Orr, G. A.; Horwitz, S. B. J. Biol. Chem. 1994, 269, 3132.
19. Rao, S.; Orr, G. A.; Chaudhary, A. G.; Kingston, D. G. I.; Horwitz, S. B. J. Biol. Chem. 1995, 270, 20235.
20. Loeb, C.; Combeau, C.; Ehret-Sabatier, L.; Breton-Gilet, A.; Faucher, D.; Rousseau, B.; Commerçon, A.; Goeldner, M. Biochemistry 1997, 36, 3820.
21. Dubois, J.; Le Goff, M.-T.; Gueritte-Voegelein, F.; Guenard, D.; Tollon, Y.; Wright, M. Bioorg. Med. Chem. Lett. 1995, 3, 1357.
22. Sengupta, S.; Boge, T. C.; Georg, G. I.; Himes, R. H. Biochemistry 1995, 36, 11889.
23. Souto, A. A.; Acuna, A. U.; Andreu, J. M.; Barasoain, I.; Abal, M.; Amat-Guerri, F. Angew. Chem., Int. Ed. Engl. 1995, 54, 2710.
24. Guy, R. K.; Scott, Z. A.; Sloboda, R. D.; Nicolaou, K. C. Chem. Biol. 1996, 3, 1021.
25. Nogales, E.; Wolf, S. G.; Khan, I. A.; Ludueña, R. F.; Downing, K. H. Nature, (London) 1995, 375, 424.
26. Georg, G. I.; Ali, S. M.; Boge, T. C.; Datta, A.; Falborg, L.; Park, H.; Mejillano, M.; Himes, R. H. Bioorg. Med. Chem. Lett. 1995, 5, 259.
27. Georg, G. I.; Harriman, G. C. B.; Ali, S. M.; Datta, A.; Hepperle, M.; Himes, R. H. Bioorg. Med. Chem. Lett. 1995, 5, 115.
28. Georg, G. I.; Boge, T. C.; Park, H.; Himes, R. H. Bioorg. Med. Chem. Lett. 1995, 5, 615.
29. Campbell, B. N.; Spaeth, E. C. J. Am. Chem. Soc. 1959, 81, 5933.
30. For recent reviews on structure-activity relationships, see: Georg, G. I.; Boge, T. C.; Cheruvallath, Z. S.; Clowers, J. S.; Harriman, G. C. B.; Hepperle, M.; Park, H. In Taxol® Science and Applications; Suffness, M., Ed.; CRC: Boca Raton, 1995; pp 317-375. Chen, S. H.; Farina, V. In The Chemistry and Pharmacology of Taxol® and Its Derivatives; Farina, V., Ed.; Elsevier: Amsterdam, 1995; pp 165-253.
31. For recent reviews on structure-activity relationships, see: Georg, G. I.; Boge, T. C.; Cheruvallath, Z. S.; Clowers, J. S.; Harriman, G. C. B.; Hepperle, M.; Park, H. In Taxol® Science and Applications; Suffness, M., Ed.; CRC: Boca Raton, 1995; pp 317-375. Chen, S. H.; Farina, V. In The Chemistry and Pharmacology of Taxol® and Its Derivatives; Farina, V., Ed.; Elsevier: Amsterdam, 1995; pp 165-253.
32. For a discussion of the various tubulin assays, see ref 29.
33. The details of this study have been published: Sengupta, S.; Boge, T. C.; Liu, Y.; Hepperle, M.; Georg, G. I.; Himes, R. H. Biochemistry 1997, 36, 5179.
34. It was recently reported that compound 9 irreversibly binds to tubulin. Ciomei, M. Abstracts of Papers, American Association of Cancer Research Meeting, Washington, DC, 1996; Abstract 1455.